Felix Kratz, Ph.D. has been appointed vice president of drug discovery at CytRx Corp. and André Warnecke, Ph.D. was named senior director of drug discovery. Drs. Kratz and Warnecke will work to expand the company’s novel albumin-binding anti-cancer drug pipeline. The company’s new lab in Freiburg, Germany will conduct discovery and translational research to create drug candidates that use novel linker technologies to generate a new pipeline of product candidates.   Dr. Kratz is a highly regarded...